ARRIVENT BIOPHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.44 USD | -0.64% |
|
-0.39% | 0.00% |
| Apr. 22 | ArriVent BioPharma, Inc. Appoints Kristine Peterson to Its Board of Directors | CI |
| Mar. 18 | ArriVent BioPharma, Inc.(NasdaqGM:AVBP) added to S&P TMI Index | CI |
Chart calendar ArriVent BioPharma, Inc.
71202d04716a548b102.EjbS7NV3nFdrHjLxoer9vT6tvJ9yTTQhvgW-xta4vEU.VFmfjYZO2DFYUWe64oiLj3XL3agkGwxxhkvQvvuPjiNoTurbvz6uBz19aw~31b05ba4137dccea7ff7fecf42d7fa02
Upcoming events on ArriVent BioPharma, Inc.
No events available
Past events on ArriVent BioPharma, Inc.
| 2024-04-04 | American Association for Cancer Research Meeting |
| 2024-03-28 04:05 pm | Q4 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 -2,50 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 -73,3 - | -80,4 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -74,6 -67,6 -10.39% | -101 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -69,3 -61,3 -13.18% | -75,7 |
|
Net income Million USD | Released Forecast Spread | -36,9 | -69,3 -61,3 -13.18% | -75,7 |
|
EPS USD | Released Forecast Spread | -1,90 | -32,4 -11,3 -186.39% | -3,68 |
| Announcement Date | 25/08/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBITDA Million USD | Released Forecast Spread | -19,2 | -19,8 | -20,4 | -21,0 | |
|
EBIT Million USD | Released Forecast Spread | -24,3 | -30,9 | -21,9 | -25,1 | -23,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,0 | -18,4 | -19,4 | -19,6 | |
|
Net income Million USD | Released Forecast Spread | -18,0 | -18,4 | -19,4 | -19,6 | |
|
EPS USD | Released Forecast Spread | -0,50 | -0,55 | -0,57 | -0,58 | |
| Announcement Date | - | - | - | - | - |
More events
Past sector events for ArriVent BioPharma, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AVBP Stock
- Calendar ArriVent BioPharma, Inc.
